EcoDrugPlus

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSSLDG00000001463
Gene Symbol: LOC111661385
3 Cross references
224 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSSLDG00000000776
Gene Symbol: RPL10
3 Cross references
405 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSSLDG00000004242
Gene Symbol: RPL10A
3 Cross references
366 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSSLDG00000024199
Gene Symbol: RPL12
3 Cross references
478 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSSLDG00000021182
Gene Symbol: RPL13
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSSLDG00000002561
Gene Symbol: RPL13A
3 Cross references
368 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSSLDG00000005405
Gene Symbol: RPL14
3 Cross references
309 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSSLDG00000020742
Gene Symbol: RPL15
3 Cross references
357 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSSLDG00000014775
Gene Symbol: RPL17
3 Cross references
79 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSSLDG00000014880
Gene Symbol: RPL18
3 Cross references
379 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSSLDG00000019582
Gene Symbol: RPL18A
3 Cross references
364 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSSLDG00000001517
Gene Symbol: RPL19
4 Cross references
287 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).